Okubo H, Ishibashi H, Shibata K, Tsuda-Kawamura K, Yanase T
Inflammation. 1984 Jun;8(2):171-9. doi: 10.1007/BF00916092.
Distribution of uptake and catabolism of intravenously administered 125I-labeled rat alpha 2-macroglobulin(125I-alpha 2MG) were examined in normal, inflammatory, and tumor tissues of rats. Clearance of intravenously administered [125I]alpha 2MG from the circulation was rapid. Accumulation of this compound into inflammatory tissue was 2-3 times more extensive than in normal tissues. The accumulation into sarcoma tissue was much less. Radioactivity in TCA-PTA precipitates remained fairly constant for the first 12 h in inflammatory tissue and for the first 24 h in sarcoma. These patterns of accumulation were never observed in the normal tissues. As the kidney preferentially accumulated large amounts of [125I]alpha 2MG in the nondegraded form and its degradation products, the tissue may play a special role in the metabolism of alpha 2MG. Rapid clearance from the circulation and relatively small amounts of accumulation in tissues suggest that alpha 2MG may function as a protease inhibitor, mainly in the circulation rather than in the tissues.
在大鼠的正常组织、炎症组织和肿瘤组织中,研究了静脉注射125I标记的大鼠α2-巨球蛋白(125I-α2MG)的摄取和分解代谢分布。静脉注射的[125I]α2MG从循环中的清除速度很快。该化合物在炎症组织中的积累比在正常组织中广泛2至3倍。在肉瘤组织中的积累则少得多。在炎症组织中,TCA-PTA沉淀物中的放射性在最初12小时内保持相当稳定,在肉瘤中则在最初24小时内保持稳定。在正常组织中从未观察到这些积累模式。由于肾脏优先以未降解形式及其降解产物积累大量的[125I]α2MG,该组织可能在α2MG的代谢中起特殊作用。从循环中快速清除以及在组织中相对少量的积累表明,α2MG可能主要在循环中而非组织中作为蛋白酶抑制剂发挥作用。